Intellia Therapeutics (NTLA) Treasury Shares: 2015-2025
Historic Treasury Shares for Intellia Therapeutics (NTLA) over the last 10 years, with Sep 2025 value amounting to $5.2 million.
- Intellia Therapeutics' Treasury Shares fell 3.79% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 3.79%. This contributed to the annual value of $5.5 million for FY2024, which is 37.26% up from last year.
- Intellia Therapeutics' Treasury Shares amounted to $5.2 million in Q3 2025, which was down 0.72% from $5.3 million recorded in Q2 2025.
- Over the past 5 years, Intellia Therapeutics' Treasury Shares peaked at $5.7 million during Q1 2024, and registered a low of $442,740 during Q1 2021.
- Its 3-year average for Treasury Shares is $4.9 million, with a median of $5.3 million in 2025.
- Per our database at Business Quant, Intellia Therapeutics' Treasury Shares spiked by 334.88% in 2022 and then dropped by 3.79% in 2025.
- Intellia Therapeutics' Treasury Shares (Quarterly) stood at $453,026 in 2021, then surged by 328.54% to $1.9 million in 2022, then surged by 108.19% to $4.0 million in 2023, then spiked by 37.26% to $5.5 million in 2024, then dropped by 3.79% to $5.2 million in 2025.
- Its Treasury Shares stands at $5.2 million for Q3 2025, versus $5.3 million for Q2 2025 and $5.5 million for Q1 2025.